Information Provided By:
Fly News Breaks for November 27, 2019
Nov 27, 2019 | 04:56 EDT
B. Riley FBR analyst Mayank Mamtani resumed coverage of Spectrum Pharmaceuticals with a Buy rating and $18 price target.
News For SPPI From the Last 2 Days
There are no results for your query SPPI